glp 1 side effect management Recommendations for managing gastrointestinal effects with 6 Common Side Effects of
Description
9, 2025), (last visited: Sep
:max_bytes(150000):strip_icc()/Common-Symptoms-From-Taking-a-GLP-1-And-How-to-Manage-Them-9e5bb7cee0484522a50dd9d7ce954cc4.jpg)
Alternatively, consider injectable semaglutide to avoid the absorption conflict entirely
[DOI] [PubMed] [Google Scholar] Thornton K, Gorenstein DG
Am J Physiol Liver Physiol 297:G861G868
According to FDA prescribing information, gallbladder-related adverse events occurred in clinical trials of semaglutide for weight management (Wegovy) at rates of 2.5% versus 1.0% with placebo, and for tirzepatide (Zepbound) at rates of 2.5% versus 1.0% with placebo
